PubMed · 1974 · 21 citations · 7 references
MedicinePathologyPharmacotherapyHepatic PharmacotherapyHepatologySystemic PathologyChronic Liver DiseaseCirrhosisHepatic Function TestingHepatic PathologyLiver DiseaseLiver Function TestsHepatic DisordersHepatic Function ChangesHepatic Function TestsInterpretation Of Liver Function TestsLiver Disease PrognosisPsoriatic Disease
A study was made of 67 severely psoriatic individuals, some of whom had received methotrexate therapy for periods varying from nine months to 14 years while others were untreated with methotrexate. Liver biopsy material from patients in both groups showed comparable histologic abnormalities regardless of treatment, including fatty changes, nuclear and mitochondrial alterations, fibrosis, and in a small percentage, frank cirrhosis. Inflammation and necrosis, however, were somewhat greater in the treated group. Minor differences in the results of liver function tests between the two groups were statistically unimportant. The concept that methotrexate therapy in psoriatics is responsible for extensive hepatic changes correlating with duration of therapy and dosage remained unsubstantiated.
7
Liver Damage due to Methotrexate in Patients with Psoriasis
M. G. C. Dahi, M. M. Gregory, Peter J. Scheuer · BMJ · 1971 · 178 citations · Full text
Medicine, Pathology, Pharmacotherapy +16
Cirrhosis Associated With Methotrexate Treatment of Psoriasis
R. Owen Coe · JAMA · 1968 · 114 citations
Hepatotoxicity of Methotrexate the Treatment of Psoriasis
Henry H. Roenigk · Archives of Dermatology · 1971 · 111 citations
Methotrexate-Induced Hepatic Injury in an Adult
Robert A. O’Rourke · Archives of Internal Medicine · 1964 · 62 citations